Psyence Biomedical Ltd

Research Psyence Biomedical Ltd (PBM) on Bullrun: market cap USD 3.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPBM
• ExchangeNASDAQ
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.17M
• Financial periodQ3 2025
• Net income-USD 753.25K
• Free cash flow-USD 4.25M

Valuation Snapshot

latest market cap is USD 3.17M.

About Psyence Biomedical Ltd

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context.

Frequently asked questions

What is Psyence Biomedical Ltd's market cap?

Psyence Biomedical Ltd's market capitalization is USD 3.17M.

What does Psyence Biomedical Ltd do?

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context.